A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
for Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
Sites in Jacksonville, Orlando +7 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: All ages
Code: NCT05788536·Phase 1, Phase 2·Recruiting·Listed Mar 2023